[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. 2434 Introduced in Senate (IS)]
<DOC>
118th CONGRESS
1st Session
S. 2434
To amend the Public Health Service Act to continue the Presidential
Advisory Council on Combating Antibiotic-Resistant Bacteria, and for
other purposes.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
July 20, 2023
Mr. Marshall (for himself and Mr. Lujan) introduced the following bill;
which was read twice and referred to the Committee on Health,
Education, Labor, and Pensions
_______________________________________________________________________
A BILL
To amend the Public Health Service Act to continue the Presidential
Advisory Council on Combating Antibiotic-Resistant Bacteria, and for
other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Presidential Advisory Council on
Combating Antibiotic-Resistant Bacteria Act'' or the ``PACCARB Act''.
SEC. 2. COMBATING ANTIMICROBIAL RESISTANCE.
Section 319E of the Public Health Service Act (42 U.S.C. 247d-5) is
amended--
(1) in subsection (a)--
(A) in paragraph (1), by inserting ``and
activities'' after ``Federal programs'';
(B) in paragraph (2)--
(i) by striking ``public health
constituencies, manufacturers, veterinary and
medical professional societies and others'' and
inserting ``the Advisory Council described in
subsection (b) and relevant public and private
entities''; and
(ii) by inserting ``, pursuant to paragraph
(4),'' after ``comprehensive plan'';
(C) by amending paragraph (3) to read as follow:
``(3) Agenda.--The task force described in paragraph (1)
shall consider factors the Secretary considers appropriate,
including factors to--
``(A) slow the emergence of resistant bacteria and
prevent the spread of resistant infections;
``(B) strengthen activities to combat resistance
through the detection of zoonotic diseases;
``(C) advance development and use of rapid and
innovative capabilities, including diagnostic tests,
for identification and characterization of resistant
bacteria;
``(D) accelerate basic and applied research and
development for new antibiotics, antifungals, and other
related therapeutics and vaccines; and
``(E) support international collaboration and
capacities for antimicrobial-resistance prevention,
detection, and control.'';
(D) by redesignating paragraph (4) as paragraph
(5);
(E) by inserting after paragraph (3) the following:
``(4) Action plan.--Not later than October 1, 2025, and
every 5 years thereafter, the task force described in paragraph
(1) shall develop and submit to the Committee on Health,
Education, Labor, and Pensions and the Committee on
Appropriations of the Senate and the Committee on Energy and
Commerce and the Committee on Appropriations of the House of
Representatives a plan regarding Federal programs and
activities to combat antimicrobial resistance, including
measurable outcomes, as appropriate, informed by the agenda
described in paragraph (3) and input provided by the Advisory
Council described in subsection (b) and other relevant
stakeholders provided pursuant to paragraph (2).'';
(2) by redesignating subsections (b) through (o) as
subsections (c) through (p), respectively;
(3) by inserting after subsection (a) the following:
``(b) Advisory Council.--
``(1) In general.--The Secretary may continue the
Presidential Advisory Council on Combating Antibiotic-Resistant
Bacteria, referred to in this subsection as the `Advisory
Council'.
``(2) Duties.--The Advisory Council shall advise and
provide information and recommendations to the Secretary,
acting through the Task Force established under subsection (a),
regarding Federal programs and activities intended to reduce or
combat antimicrobial-resistant bacteria or fungi that may
present a public health threat and improve capabilities to
prevent, diagnose, mitigate, or treat such resistance. Such
advice, information, and recommendations may be related to
improving Federal efforts related to factors described in
subsection (a)(3) and other topics related to antimicrobial
resistance, as appropriate.
``(3) Meetings and coordination.--
``(A) Meetings.--The Advisory Council shall meet
not less than biannually and, to the extent
practicable, in coordination with meetings of the task
force established under subsection (a).
``(B) Coordination.--The Advisory Council shall, to
the greatest extent practicable, coordinate activities
carried out by the Council with the task force
established under subsection (a).
``(4) FACA.--Chapter 10 of title 5, United States Code,
shall apply to the activities and duties of the Advisory
Council.''; and
(4) in subsection (n), as so redesignated, by striking
``(f) through (j)'' and inserting ``(g) through (k)''.
<all>